Weight reduction drug makers Eli Lilly and Novo Nordisk on Thursday secured offers with the Trump administration to cut back costs for his or her blockbuster weight-loss medication.
“It’s a triumph for American sufferers that can save lives and enhance the well being of thousands and thousands and thousands and thousands of People,” Trump advised reporters within the Oval Workplace.
Mike Doustdar, chief government officer of Novo Nordisk, stated in an announcement that “Novo Nordisk has all the time labored to safe inexpensive entry to our modern medicines, and as we speak’s announcement will carry semaglutide medicines to extra American sufferers at a decrease value.
Lilly Chief Government Officer Dave Ricks in an announcement known as the announcement a pivotal second in US well being care coverage that was “made attainable via collaboration with the Trump Administration.”
What can be the price of weight reduction medication when bought via TrumpRx?
— Ozempic and Wegovy costs will fall from $1,000 and $1,350 per 30 days, respectively, to $350.
— Zepbound and Orforglipron, if accepted, will fall from $1,086 per 30 days to a mean of $346.
The White Home stated that within the occasion that the FDA later approves the Wegovy tablet, or sure related ‘GLP-1’ medication in every firm’s pipeline supposed to be taken orally reasonably than as a shot, the preliminary dose of these medication can be priced at $150 per 30 days via TrumpRx.
— The Medicare costs of Ozempic, Wegovy, Mounjaro, and Zepbound can be $245.
— Medicare beneficiaries pays a co-pay of simply $50 per 30 days.
